Rhythm Biosciences Limited (ASX:RHY)
0.200
+0.015 (8.11%)
At close: Mar 9, 2026
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 65.60 million as of March 9, 2026. Its market cap has increased by 159.89% in one year.
Market Cap
65.60M
Enterprise Value
64.13M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 65.60M, an increase of 100.33%. That is a compound annual growth rate of 8.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cryosite | 58.57M |
| Microba Life Sciences | 49.93M |
| INOVIQ | 46.46M |
| BCAL Diagnostics | 44.17M |
| Genetic Signatures | 21.58M |
| Monash IVF Group | 257.16M |
| Imagion Biosystems | 9.81M |
| Australian Clinical Labs | 416.48M |